논문번호 | 11 | ||
논문제목(영문) | Clinical experiences of coronary MAC (Maximum Arterial Re-Creation) stent. | ||
국내외구분 | 국내 | SCI여부 | SCI(E) |
연구책임자역할 | 교신저자 | ||
주저자명 | Kim SH | ||
교신저자명 | Jeong MH | ||
공동저자명 | Kim SH, Jeong MH, Jang YS, Bae Y, Kim JW, Cho JH, Kim NH, Park WS, Ahn Y, Cho JG, Park JC, Kang JC; | ||
게제년월일 | 1998-11-19 | ||
ISSN | 1738-5520 | ||
Impact Factor | 0.753 | ||
학술지명 | Korean Circulation J | ||
서지사항 | 0집 / 28권 / 10호, 페이지(1700 - 1706) | ||
요약초록문 (Abstract) 입력 |
Background and Objectives:We previously reported the effects of MAC (Maximum Arterial Re-Creation) stent on stent restenosis in a porcine model. The clinical trial was performed in patients with ischemic heart disease after MAC stent implantation. Materials and Method:We analyzed the clinical and angiographic re-sults in 20 patients in 22 lesions (15 M, 5 F, 59±11 year), who underwent MAC stent at Chonnam University Hospital between Nov ’97 and Aug ’98. Clinical diagnosis was 13 unstable angina (65%), 6 acute myocardial infarction (30%) and 1 old myocardial infarction (5%). Results:Indications for stent were 3 de novo lesion (13.6%), 7 restenosis (31.8%), 8 suboptimal angioplasty result (36.4%) and 4 bail-out procedure (18.2%). Target stented coronary arteries were 15 left anterior descending coronary arteries (67.3%), 2 left circumflex coronary arteries (9.1%) and 5 right coronary arteries (22.7%). Morphologic types were 13 type B1 (59.1%), 5 B2 (22.7%) and 4 C (18.2%). Minimal luminal diameter (MLD) before stent was 0.75±0.35 mm and percent diameter stenosis (DS) was 75±11.5%, which were improved 2.97±0.28 mm in MLD and 2.79±5.4% in DS after stent. MAC stent was placed successfully in all patients and one case of acute stent thrombosis was improved after ReoPro infusion. Mean follow-up period was 5.2±3.2 months and 100% event-free survival was observed in all patients. Follow-up coronary angiography was performed in 5 patients and showed no stent restenosis. Conclusion:The MAC stent is one of effective and safe devices in the treatment of coronary artery diseases without significant complications and target vessel revascularization. |
||
파일 |
C11. Korean Circulation J 1998;28(10)1790-1793..pdf (4.1M) DATE : 2016-03-13 19:53:49 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved